GLP-1 drugs like Wegovy, Zepbound, Ozempic, and Mounjaro are transforming care—but without the right guardrails, costs can spiral. Our GLP-1 Planning Checklist gives HR and Finance leaders 7 proven strategies to balance cost, access, and outcomes.
If you manage employer benefits, you’re staring at a 2026 puzzle: demand for GLP-1 medications keeps climbing while prices remain elevated, and oral options may expand utilization further.
They promise weight loss. But without a plan, GLP-1s can quietly become your biggest prescription care expense.
An expert-led webinar with a pharmacist, a nurse, a doctor, and an HR leader sharing practical steps employers should take to balance cost, access, and outcomes